In this issue of JAMA Dermatology, Cheraghlou et al1 compare the survival of patients with stage I melanoma treated with Mohs micrographic surgery (MMS) and wide local excision (WLE) in the National Cancer Database (NCDB). The treatment of melanoma with MMS has historically been the subject of controversy, with physicians on either side deeply entrenched in their views. The investigators’ finding that patients undergoing MMS have improved survival, although relatively novel, is not surprising.